Skip to main content
Caplight Logo









Splose

Splose

Private
AdelaideHealthcare & Life Scienceshttps://splose.com/

Last Round

Series A

Feb 8, 2026

Total Funding Raised

$34.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Splose is a healthtech company that develops a practice management software designed to streamline operations for Allied Health and NDIS providers using AI and automation.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, EHR & EMR, Medical AI, Workflow Automation, CRM

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Payment Processing Fee

AI Layer

Application

Keywords

allied health softwarepractice management softwareclinical documentationNDIS provider softwarevertical SaaSmedical AIEMRpatient schedulingmedical billing softwareEHRAI scribeworkflow automationAI copilotonline formspayment processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Splose Comparables

Compare Splose with similar companies based on industry and business-model similarity.

Splose comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cliniko
90%
Halaxy
83%
Carepatron
83%

Splose Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 8, 2026
SeedFeb 21, 2025

Key People

Founding team and executive leadership

Kon Knafelman

Chief Financial Officer

Executive Team

Anna Kelk

Chief Product Officer

Executive Team

Splose Investors

Notable investors and investment history

Splose investors
InvestorRounds
South Australia GovernmentGrant
Spectrum EquitySeries A
Equity Venture PartnersSeries A, Seed
Athletic VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 8, 2026

    $32M round led by Spectrum Equity.

  • Jan 23, 2026

    Grew 28% QoQ, from 58 to 74 employees.

Splose Filings

Explore SEC and related filing metadata, where available.

Splose filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Splose's valuation, stock price, and market status.

Is Splose a public or private company?

Splose is a private company.

What is the current stock price of Splose?

Splose is a private company with no public stock price. No recent secondary market data is available.

How much is Splose worth (valuation)?

Valuation information for Splose is not publicly available.

Can I buy Splose stock?

Splose shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Splose's last funding round?

Splose's most recent funding round was Series A on February 8, 2026.

Who are the main investors in Splose?

Key investors in Splose include Spectrum Equity, Equity Venture Partners.

Will Splose IPO soon?

No public IPO plans have been announced for Splose.

How can I track Splose secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Splose's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAdelaide
Employee Range83
Year Founded2016
Last FundingFeb 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?